Medicare Enrolled

Dr. David Kung, M.D.

Rheumatology · Cedar Park, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1401 MEDICAL PKWY STE 220, Cedar Park, TX 78613
5122601581
Registered in NPPES since 2012
NPI: 1134474653 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kung? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kung

Dr. David Kung is a rheumatology specialist in Cedar Park, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Kung performed 8,092 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kung received a total of $5,643 from 26 pharmaceutical and/or device companies across 335 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kung is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ Top 39% volume in TX $5,643 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
8,092
Medicare services
Top 39% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 5,460 $18 $33
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
475 $84 $238
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
279 $10 $47
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
250 $8 $35
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
239 $5 $24
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
226 $1 $6
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
218 $3 $8
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
215 $55 $165
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
119 $114 $295
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
105 $96 $310
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
89 $29 $76
Phosphate level test
A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong.
80 $5 $22
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
66 $7 $30
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
65 $6 $73
Autoimmune disorder antibody test
A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders.
37 $16 $50
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
32 $54 $164
DNA antibody test (native or double-stranded)
A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body.
26 $13 $38
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $49 $168
Tuberculosis blood test (gamma interferon)
A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels.
21 $56 $174
Rheumatoid factor level 19 $6 $17
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
18 $12 $37
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
16 $35 $108
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
13 $45 $145
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.5% high complexity
74.3% medium
24.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,643
Total received (2018-2024)
Avg $806/year across 7 years
Top 43% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
335
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$283
2023
$674
2022
$584
2021
$664
2020
$348
2019
$1,644
2018
$1,446

Payments by company (2024)

ABBVIE INC.
$87
Janssen Biotech, Inc.
$70
UCB, Inc.
$47
Fresenius Kabi USA, LLC
$35
E.R. Squibb & Sons, L.L.C.
$28
Amgen Inc.
$16
Top 3 companies account for 72.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$970
Janssen Biotech, Inc.
$778
ABBVIE INC.
$667
AbbVie, Inc.
$585
UCB, Inc.
$511
Genentech USA, Inc.
$309
AbbVie Inc.
$295
PFIZER INC.
$259
E.R. Squibb & Sons, L.L.C.
$212
GENZYME CORPORATION
$176
Horizon Therapeutics plc
$131
Celgene Corporation
$104
Radius Health, Inc.
$98
GlaxoSmithKline, LLC.
$80
Lilly USA, LLC
$71
Horizon Pharma plc
$68
Abbott Laboratories
$64
Novartis Pharmaceuticals Corporation
$64
Sobi, Inc
$42
Fresenius Kabi USA, LLC
$35
Antares Pharma, Inc.
$31
AstraZeneca Pharmaceuticals LP
$24
Takeda Pharmaceuticals U.S.A., Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Vertiflex, Inc.
$14
Mallinckrodt LLC
$14
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUEXIS · EVENITY · Enbrel · Entyvio · FORTEO · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LYRICA · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · PROCLAIM · Penta SCS Leads · Proclaim Family of SCS IPGs · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SCS leads · SIMPONI ARIA · SKYRIZI · STELARA · Superion ISS · TALTZ · TREMFYA · Tavneos · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Cedar Park?
Compare rheumatologists in the Cedar Park area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
28
County median income
$108,309
Nearest hospital to ZIP centroid (approximate)
CEDAR PARK REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kung is a mixed practice specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kung experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kung performed 5,460 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kung receive payments from pharmaceutical companies?
Yes. Dr. Kung received a total of $5,643 from 26 companies across 335 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kung's costs compare to other rheumatologists in Cedar Park?
Dr. Kung's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →